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Abstract
Background: Genes conferring antibiotic resistance to groups of bacterial pathogens are cause for considerable
concern, as many once-reliable antibiotics continue to see a reduction in efficacy. The recent discovery of the
metallo b-lactamase blaNDM-1 gene, which appears to grant antibiotic resistance to a variety of Enterobacteriaceae
via a mobile plasmid, is one example of this distressing trend. The following work describes a computational
analysis of pathogen-borne MBLs that focuses on the structural aspects of characterized proteins.
Results: Using both sequence and structural analyses, we examine residues and structural features specific to
various pathogen-borne MBL types. This analysis identifies a linker region within MBL-like folds that may act as a
discriminating structural feature between these proteins, and specifically resistance-associated acquirable MBLs.
Recently released crystal structures of the newly emerged NDM-1 protein were aligned against related MBL
structures using a variety of global and local structural alignment methods, and the overall fold conformation is
examined for structural conservation. Conservation appears to be present in most areas of the protein, yet is
strikingly absent within a linker region, making NDM-1 unique with respect to a linker-based classification scheme.
Variability analysis of the NDM-1 crystal structure highlights unique residues in key regions as well as identifying
several characteristics shared with other transferable MBLs.
Conclusions: A discriminating linker region identified in MBL proteins is highlighted and examined in the context
of NDM-1 and primarily three other MBL types: IMP-1, VIM-2 and ccrA. The presence of an unusual linker region
variant and uncommon amino acid composition at specific structurally important sites may help to explain the
unusually broad kinetic profile of NDM-1 and may aid in directing research attention to areas of this protein, and
possibly other MBLs, that may be targeted for inactivation or attenuation of enzymatic activity.
Background
Proteins within the b-lactamase family have long drawn
the attention of researchers and clinicians due to their
ability to efficiently hydrolyze many common antibiotics.
Metallo b-lactamases (MBLs) in particular are of global
health interest, as many are acquired, capable of travel-
ing across species, and are the most commonly encoun-
tered transferable carbapenemases [1]. The recently
discovered plasmid-borne New Delhi metallo b-lacta-
mase (NDM-1), capable of hydrolyzing a broad range of
antibiotics, is such a metalloenzyme and is noted for its
ability to confer resistance to all but a small handful of
b-lactam antimicrobials. First characterized within a
Swedish patient of Indian origin in 2008 [2], NDM-1
has since been identified in other parts of Asia, North
America, Europe, Australia and Africa [3-8].
In addition to its rapid worldwide dissemination,
NDM-1 is alarming for its penchant to transfer between
species via conjugation. With its initial identification on
a1 8 0 - k bKlebsiella pneumoniae plasmid, and subse-
quent re-discovery on a Escherichia coli plasmid isolated
from the same patient, NDM-1 has displayed an ability
to spread amongst bacteria [2], and more recent findings
have identified it in additional members of the Entero-
bacteriaceae family [9,10]. Moreover, the presence of the
gene encoding NDM-1 within isolates has been
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ments which confer additional resistance against other
forms of antibiotics, including monobactams, aminogly-
cosides, fluoroquinolones and tetracyclines [5,9,11],
further reducing treatment options for infected patients.
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to greatly impact global health, most immediately in
hospital settings through nosocomial infections, which
appear to be a common mode of infection for NDM-1
carrying bacteria [4]. Further knowledge of the mechan-
isms of the encoded protein may help to expedite devel-
opment of therapies and countermeasures. Preliminary
characterization of NDM-1 conducted by Yong and col-
leagues revealed marginal sequence similarity to other
members of the MBL family, with the closest sequence
homology to VIM-1 and VIM-2 at only 32%; kinetic stu-
dies supported this association, although NDM-1 was
noted to possess a superior binding profile for most b-
lactams compared to VIM-type proteins [2]. They
further identified, using sequence alignment, novel fea-
tures of the NDM-1 protein not found in other mem-
bers of the MBL family, such as uncommon residues
around the zinc binding site and a four-residue insertion
not observed in other MBLs. These features may help
provide NDM-1 with its capability to readily bind to a
very broad range of b-lactams. Other, more well-known
MBLs such as the VIM-type proteins found in Pseudo-
monas, have likewise spread rapidly since their initial
discoveries [12-15]. Many infections have been trans-
mitted nosocomially, and are often found in developing
areas [4,16]. Further knowledge of the mechanisms of
these metalloenzymes may help to expedite development
of inhibitors with direct clinical significance.
The variety, structure, function and medical signifi-
cance of these proteins have been the focus of much
research in the past, and they may be classified both
molecularly and functionally. Traditionally, MBL pro-
teins are categorized as “class B” b-lactamases, which
can be further divided into subclasses based on the nat-
ure of the metal binding site. The presence of specific
binding motifs around the active cavity of the proteins,
associated with zinc binding and coordination, may be
used to classify an MBL as either B1 (zinc binding at
H116-H118-H196 and at D120-C221-H263), B2 (N116-
H118-H196; D120-C221-H263) or B3 (H/G116-H118-
H196; D120-H121-H263) [17]. Notably, four of the six
conserved residues are static across all classes, allowing
amino acid-based molecular classification at only two
positions (H/N/G116 and C221/H121). This classifica-
tion scheme, though simple, is thought to be strongly
related to the structural plasticity of the enzymes, as the
zinc binding sites are critical to the hydrolytic effects of
MBLs. Functional groupings have also been used as a
means of describing similarities between MBLs.
Inhibition by EDTA, substrate hydrolysis rates and pro-
files created by testing against other inhibitors (e.g.,c l a -
vulanic acid) can be used to profile clinically relevant
groups of MBL proteins and identify isolates in the lab
[18,19].
Prior research on the structure-function relationship
of MBL proteins has focused primarily on the region of
the active site and mechanism of catalysis. For di-zinc
MBLs, hydrolysis is believed to occur via breaking of
the b-lactam amide bond on the carbonyl by a resident
hydroxide in the active site. This action is zinc-activated,
and creates a temporary intermediate tetrahedral carbon,
upon which the zinc-bound water donates a proton to
the leaving nitrogen of the ligand [20-23]. The steps
involved in this action are believed to be ligand-depen-
dent, and protonation may or may not coincide with
cleavage of the b-lactam ring (e.g., as noted for nitroce-
fin bound to ccrA) [24]. For B1 MBLs, binding is
thought to be mediated in part by the presence of a
large mobile flap that forms a cleft over the active site
[21]. Deletion of this flap region in some MBLs has
been correlated with weakened affinity for many antibio-
tic substrates, with the exception of imipenem [25]. The
mobile flap exists in B1 MBL types ccrA and IMP-1
with an aromatic, bulky residue, and has been hypothe-
sized to be critically involved in the recruitment, stabili-
zation and binding of inhibitors [21,26,27]. This flap is
less functionally important in VIM-2, which contains an
alanine (A64) in place of an aromatic residue [28],
exemplifying the nuanced structural functionality of
common B1 MBL components.
The prevalence of methods for classifying MBLs is in
large part due to their functional, structural and mole-
cular similarities and differences, and our work builds
upon the features used for classification currently receiv-
ing attention by applying structure-based analyses of
well-characterized MBLs, with the hope of identifying
residues and regions that can further aid in functional
discrimination. A more detailed picture of residue con-
servation and structural uniqueness is assembled for
proteins within the B1 MBL subclass, and its constituent
types VIM, IMP, ccrA and NDM-1. While the core
structure of MBLs is well known to be conserved, struc-
tural alignments revealed a “linker” region with consid-
erable variability among B1 proteins, which we propose
as a notable structural classification feature. We apply
structural analysis methods to the NDM-1 protein in
order to identify significant sequence and structural dif-
ferences from other MBLs that may affect NDM-1’s
a b i l i t yt ob i n dt oa n t i b i o t i cs. Recently solved crystal
structures of the NDM-1 protein [23,29,30] are com-
pared with B1 subfamilies IMP-, ccrA- and VIM-type
structures for the purposes of identifying distinctive fea-
tures. Using structure-based sequence variability
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served residues were identified in NDM-1 and compared
with the corresponding residues in similar proteins to
identify regions of conservation and novelty between the
known and new B1 MBLs. Many sites we identify com-
putationally as highly conserved correspond to those
found to be functionally critical by prior experimental
work. Common themes, as well as features unique to
NDM-1, are identified. Of particular interest is an
uncharacteristically divergent “linker” region. We find
that while the vast majority of B1 MBLs’ conformation
is well conserved, NDM-1 is marked by both the pre-
sence of rare residues in resistance-implicated regions
and a linker conformation that is unique among MBL
structures.
Methods
MBL-like protein structure library
As one goal of this study was an overall structural char-
acterization and comparison of available B1 MBL struc-
tures, with emphasis on the recently discovered NDM-1
protein, a library of B1 MBL proteins for which both
sequence and structure were available was generated.
Protein structures were retrieved from the Protein Data
Bank (PDB) [31], and full sequences were taken from
UniProt [10]. Special focus was given to three specific
B1 types used in comparison to NDM-1 from prior
research: IMP-1, VIM-2 and ccrA [2,23,29,30].
Representatives of IMP-1 (PDB: 1ddk_A), VIM-2 (PDB:
1ko3_A), ccrA (PDB:1hlk_A) and NDM-1 (PDB: 3q6x_A)
were selected as seed structures for expanding the number
of structures used for variability analysis (see 2.2) to include
similar, MBL and MBL-like, proteins; these representatives
are used as the reference structures for their respective
types throughout the rest of our study, unless otherwise
noted. Figure 1 shows structure-based sequence alignment
between the selected representatives, showing strong over-
all correspondence with relatively few gaps. Structure-
based similarity searches were performed for IMP-1, VIM-
2, ccrA and NDM-1 against the entire PDB database
(release 2011/08/02; 188,448 chains) using the StralSV
algorithm [32]. Pruning of the retrieved structures was per-
formed via an LGA_S [33] cutoff value of ≥ 50% structure
similarity to the corresponding reference structures. After
removing PDB chains identical in sequence, the result con-
sisted of 75 structures. This set of proteins was expanded
to include all available NDM-1 crystal structures (nine, as
of the writing of this manuscript), which formed the final
MBL fold library (83 structures; refer to Additional file 1)
used for comparative computational analysis.
Comparative structural analysis
Members of the MBL-like library were subjected to a
number of comparative methods in order to determine
distinctive regions of conservation and divergence.
Structure-based sequence variability analyses were run
for the representative structures of NDM-1, IMP-1,
VIM-2 and ccrA, using StralSV [32], which calculates
sequence variability from fragment-based local structural
alignment. The purpose of this analysis was to identify
in analyzed MBL structures local regions where proteins
are structurally unique, and regions where they are rela-
tively conserved regardless of their sequence similarity,
focusing on sequence compositions in such regions.
The StralSV algorithm works, briefly, as follows: a tar-
get structure, t, and associated library, L, are specified.
Template structure l Î L shares structural similarity
with t in at least some structural fragments. Detection
of local similarities and calculations of alignments
between t and all l are performed using the LGA pro-
gram [33], and the specific residue-residue correspon-
dences for t and each member of L are found. Thus, for
each position in t, a residue “profile” is built using resi-
dues from L with which that position structurally aligns.
The output allows one to examine commonalities and
eccentricities between a target and any number of tem-
plates at the structural level, much like a sequence-
based profile would allow one to examine standard posi-
tional variability.
To determine structural groupings and gain better
insight into both overall and region-specific similarities
between MBLs, clustering of the structures was per-
formed using StralCP [34] on a whole-chain level and
for two specific local substructures selected for their
importance or uniqueness: the active site and the linker
region, the latter identified from structural variability
analysis to be unique in NDM-1 (see 3.1). Clusters were
formed hierarchically using Euclidean distance measure-
ments from n-way multiple structural alignments. For
whole-chain clusters, terminal regions were trimmed to
reduce length bias, while for linker region clustering,
corresponding fragments in other MBLs were identified
through structural comparisons with a reference struc-
t u r eo fN D M - 1( s e eF i g u r e2 ) .F o re x a m p l e ,f o rt h e
reference ccrA, IMP-1, VIM-2 and NDM-1, the frag-
ments correspond to residues 120-166, 98-143, 138-200
and 141-193, respectively, and include N- and C-term-
inal anchor sequences that flank the linker region. The
active site local environment was delineated using an
initial 7.5 Å radius spheres centered at the metal ions.
Residues within this radius then formed the core of
another, second set of 7.5 Å spheres to produce an addi-
tional layer of functional residues. The sphere size was
selected in order to capture as much functional informa-
tion around the local environment as possible, and pre-
vious research indicated that distances of 7.5 Å are an
upper limit in capturing informative functional proper-
ties for clustering purposes [35].
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were measured, and CASTp [36] was used to estimate
binding site volumes for B1 MBLs. Because apo and
h o l of o r m so fI M P - 1 ,V I M - 2 ,c c r Aa n dN D M - 1w e r e
available, systematic comparisons of differences in back-
bone conformation and ligand binding were made.
Changes in small molecule binding within IMP-1, VIM-
2 and ccrA at the side chain level were compared to
NDM-1 for the purpose of classifying NDM-1’sf u n c -
tional residue profile using a new pairwise structural
comparison service, LGA_pdblist http://proteinmodel.
org/AS2TS/LGA_list/.
Comparisons of critical residues based on structural
alignments
Pairwise LGA comparisons were used to examine cataly-
tic and critical residues found in IMP, VIM, ccrA and
NDM-1, for the purpose of identifying shared or distinc-
tive conformational changes in the immediate vicinity of
metal and ligand binding. Using structural alignments as
a scaffold, residue-residue correspondences were gener-
ated for B1 MBLs using NDM-1 as a reference. Bound
representatives were used for this purpose in order to
identify ligand-interacting residues (3q6x_A, 1dd6_A,
1a8t_A, 2yz3_A for NDM-1, IMP-1, ccrA and VIM-2,
respectively). Residues specifically examined include
those within 4 Å of either the zinc ions or bound
ligands. Additionally, residues thought to be critical for
other MBL variants based on experimental evidence
found in literature, but located outside the active site,
were also included and mapped onto NDM-1 for
reference.
Results and discussion
Overall MBL structure
In the present study, focus was placed on B1 MBLs as a
way of generalizing toward emerging, transferable anti-
biotic resistance genes, such as NDM-1. A global exami-
nation of the proteins most closely related to NDM-1
highlighted structural commonalities across B1 MBLs.
Comparisons with available NDM-1 structures to the
pre-selected MBL-like fold library yielded similar scores,
with the closest proteins being representatives from
VIM (VIM-2, VIM-4) and ccrA; Figure 2 shows a heat-
map of structural alignments of NDM-1 against the pre-
selected MBL library, indicating strong (< 2 Å of Ca-Ca
deviation; colored in green) structural concordance in
the majority of regions for most other MBLs. The simi-
larity of NDM-1’s overall conformation to many other
MBLs despite low sequence identity is unsurprising as
3q6x_A (NDM-1)   30  EIRPTIGQQMETGDQRFGD-LVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVD   90
1ddk_A (IMP-1)    2  --------------eslpD-LKIEKLDEGVYVHTSFEEVngwgVVPKHGLVVLVNAEAYLID   48
1ko3_A (VIM-2)   30  -------eyptvseipvGE-VRLYQIADGVWSHIATQSFdg-aVYPSNGLIVRDGDELLLID   84
1hlk_A (ccrA)    21  -------------SVKISDdISITQLSDKVYTYVSLAEIegwgMVPSNGMIVINNHQAALLD   69
3q6x_A (NDM-1)   91  TAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQE  152
1ddk_A (IMP-1)   49  TPFTAKDTEKLVTWFVER-GYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELTNELLKKD  109
1ko3_A (VIM-2)   85  TAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEVE  149
1hlk_A (ccrA)    70  TPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTIDLAKEK  131
3q6x_A (NDM-1)  153  GMVAAQHSLTF-AANGWVEPATAPNFG----PLKVFYPGPGHTSDNITVGIDGTDIAFGGCL  209
1ddk_A (IMP-1)  110  GKVQATNSFSG-----vnyw-----lv--knKIEVFYPGPGHTPDNVVVWLPERKILFGGCF  159
1ko3_A (VIM-2)  150  GNEIPTHSLEGlsssgdavr-----fg----PVELFYPGAAHSTDNLVVYVPSASVLYGGCA  222
1hlk_A (ccrA)   132  GLPVPEHGFTD------slt-----vsldgmPLQCYYLGGGHATDNIVVWLPTENILFGGCM  182
3q6x_A (NDM-1)  210  IKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR-  270
1ddk_A (IMP-1)  160  IKP--y-GLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLn  218
1ko3_A (VIM-2)  223  IYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAhtn  295
1hlk_A (ccrA)   183  LKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIe  244
YANALSNQLAPQE  
YASELTNELLKKD  
YASPSTRRLAEVE  
YANQMTIDLAKEK  
 GMVAAQHSLTF-AANGWVEPATAPNFG----PLKVFYPGPGHTSDNI
 GKVQATNSFS IEVFYPGPGHTPDNVV
 GNEIPTHSLE VELFYPGAAHSTDNLV
 GLPVPEHGFT LQCYYLGGGHATDNIV
TF-AANGWVEPATAPNFG----PL
G-----vnyw-----lv--knK
Glsssgdavr-----fg----PV
TD------slt-----vsldgmPL
YLDMPGFGAVA
FEEVngwgVVP
TQSFdg-aVYP
LAEIegwgMVP
IKDSKAKSLGNLGDADTEH
IKP--y-GLGNLGDANIEA
IYELSRTSAGNVADADLAE
LKDNQATSIGNISDADVTA


 

Figure 1 Structure-based sequence alignment of NDM-1, IMP-1, VIM-2 and ccrA. Alignments were generated using LGA with NDM-1
(3q6x_A) as the reference. Capitalized amino acids indicate structural residue-residue correspondence, whereas lowercase amino acids indicate
regions in MBLs where no structural alignment with NDM-1 can be identified. Regions of interested are denoted by boxes and labeled as the
mobile flap (1, blue) (residues 65-73 in NDM-1; 23-31 in IMP-1; 59-67 in VIM-2; and 44-52 in ccrA), the linker region including anchoring regions
(2, blue) (residues 141-193 in NDM-1; 98-143 in IMP-1; 138-200 in VIM-2; and 120-166 in ccrA), the non-aligning linker region core (3, red)
(residues 163-179 in NDM-1; 120-129 in IMP-1; 174-186 in VIM-2; and 142-152 in ccrA), and the L10 loop (4, blue) (residues 210-227 in NDM-1;
160-174 in IMP-1; 223-240 in VIM-2; and 183-200 in ccrA). Notably, ccrA is the only B1 MBL gap free with respect to NDM-1 outside of the linker
region.
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Page 4 of 15proteins under the B1 MBL grouping are well known to
adopt very similar folds and active regions [14]. How-
ever, we note that there are significant regions of diver-
gence, which include the so-called L3 mobile flap,
whose motion is associated with MBL ligand binding,
and a “linker” loop region commonly found in MBLs.
Within VIM-2 this region corresponds to residues 174-
186, in IMP it is found between residues 120-129, ccrA
residues 142-152 and NDM-1 163-179 (see Figure 1).
Structural alignment was generally poor between MBL-
types within this region, and it was thus singled out for
further analysis.
3q6x_A  NDM-1                                                                                                                    100.00  100.00
3spu_B  NDM-1                                                                                                                    99.14   95.82
3sfp_A  NDM-1                                                                                                                    100.00   94.38
3zr9_A  NDM-1                                                                                                                    100.00   94.33
3srx_A  NDM-1                                                                                                                    99.56   94.27
3sbl_A  NDM-1                                                                                                                    100.00   93.15
3rkj_A  NDM-1                                                                                                                    100.00   92.27
3rkk_A  NDM-1                                                                                                                    100.00   92.02
1znb_B  ccrA 31.19   84.81
1bmi_B  ccrA 31.22   84.77
3s0z_A  NDM-1                                                                                                                    95.77   84.65
2y8b_A  VIM-7                                                                                                                    32.72   84.30
1ko3_A  VIM-2                                                                                                                    36.11   84.14
1a7t_A  ccrA 30.59   84.10
4znb_A  ccrA 30.41   84.00
2y87_A  VIM-7                                                                                                                    33.49   83.90
2whg_A  VIM-4                                                                                                                    35.81   83.77
2yz3_A  VIM-2                                                                                                                    37.09   83.25
1ko2_A  VIM-2                                                                                                                    35.81   82.93
1dxk_A  BcII 29.77   82.91
2bfl_B  BcII 30.84   82.79
2bg7_B  BcII 30.52   82.57
3fcz_A  BcII 31.31   82.48
1hlk_A  ccrA 30.66   82.34
1wuo_A  IMP-1                                                                                                                    33.65   81.84
2uyx_A  BcII 30.66   81.80
1wup_A  IMP-1                                                                                                                    34.45   81.63
1ddk_A  IMP-1                                                                                                                    33.97   81.57
1mqo_A  BcII 30.84   81.55
3kns_A  BcII 30.66   81.47
2nze_B  BcII 31.13   81.42
1jjt_A  IMP-1                                                                                                                    33.97   81.38
1jje_B  IMP-1                                                                                                                    33.82   81.36
2fhx_A  SPM-1                                                                                                                    25.71   81.14
2nyp_A  BcII 30.00   80.71
2nzf_A  BcII 30.00   80.53
1bmc_A  BcII 30.62   80.25
3i14_A  BcII 30.14   80.08
1m2x_A  BlaB 25.35   78.77
3l6n_A  IND-7                                                                                                                    25.59   77.97
3iog_A  CphA 22.55   77.86
1x8h_A  CphA 22.44   77.63
2qds_A  CphA 22.28   77.27
3q6v_A  Sfh-I                                                                                                                             18.41   77.10
2cfu_A  SDSA1                                                                                                                 14.85   58.23
2cg3_A  SDSA1                                                                                                                 15.66   55.97
2q0i_A  PqsE 15.54   55.87
1qh5_A  Glyoxylase 18.29   55.19
3dh8_A  PqsE 14.66   54.90
2vw8_A  PqsE 15.10   54.78
2q0j_A  PqsE 14.95   54.50
2qin_C  L1                                                                                                                    18.42   54.21
1sml_A  L1                                                                                                                    19.25   53.49
2qjs_A  L1                                                                                                                    18.09   53.31
2xf4_A  Glyoxalase 12.36   53.31
2p18_A  Glyoxalase 16.22   53.27
2ohh_A  FprA 14.65   52.80
1k07_A  FEZ-1                                                                                                                    13.30   52.51
3adr_A  MBL-like                                                                                                                 11.60   52.45
1xm8_A  Glyoxalase 20.44   52.27
1l9y_A  FEZ-1                                                                                                                    13.23   52.02
2gcu_A  MBL-like                                                                                                                 18.64   51.99
2p97_A  Hydrolase 11.60   51.09
2zwr_B  MBL-like                                                                                                                 18.64   50.94
1ycg_A  FprA 13.68   50.68
2zo4_A  MBL-like                                                                                                                 16.76   50.27
1e5d_A  ROO                                                                                                                   11.70   49.92
2br6_A  Lactonase 12.88   49.71
2gmn_A  BJP-1                                                                                                                    15.87   49.64
1vme_A  Flavoprote 13.44   49.64
2obw_A  Glyoxalase 18.82   49.14
3dha_A  Lactonase 12.12   48.42
2q9u_A  FDP                                                                                                                   14.14   48.27
3m8t_A  BJP-1                                                                                                                    15.59   48.19
3aj3_A  Lactonase 13.33   48.11
2r2d_A  AiiB 10.91   48.11
3hnn_A  Flavoprote 12.57   47.99
2a7m_A  Hydrolase 12.73   47.64
1p9e_A  MP-hydrola 17.05   47.28
3aj0_A  Lactonase 13.58   46.90
3r2u_A  MBL-like                                                                                                                 15.79   46.48
3esh_A  Hydrolase 9.71   46.11
2az4_B  MBL-like                                                                                                                 12.42   42.10
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Figure 2 Heatmap LGA alignments of MBL library against NDM-1. Parameters for LGA were set using a maximal 4.0 Å distance, under side
chain comparison. Coloring was set to > 2 Å (at 2 Å increments) from green to yellow to orange to red to gray. Notable areas of interested are
framed using the same ranges as in Figure 1, and include regions of major structural misalignment, such as the L3 mobile flap and the linker
region.
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Page 5 of 15Beginning at the active site, StralSV analysis of IMP-1,
VIM-2, ccrA and NDM-1 type representatives against
the preselected MBL library showed well-conserved
structural alignment profiles around the di-nuclear zinc
binding motif; conservation signals at both the sequence
and structure level was strongly evident for the HxHxD
zinc binding motif in all four MBLs, even while sur-
rounding residues were generally heterogeneous within
the MBL library. Chains that matched this structural
region, but did not correspond to the B1 HxHxD, motif
were generally B2 MBLs (with an NxHxD motif) or oxi-
doreductases (e.g., HxExD), illustrating the overall
shared conformation of the binding pocket despite var-
iation between actual residues.
Select regions of the B1 MBLs, and indeed the entire
library, are less in consensus. As noted previously, the
L3 flap region at the entrance to the binding cavity is
observed in different local structural conformations in
analyzed MBLs. Analysis of the flap region for VIM,
IMP and ccrA highlights the divergence between the
structures of this flap across B1 MBLs. While known to
be functionally important in IMP and ccrA, sequence
conservation is limited and structural profiles are het-
erogeneous due to the region’s mobility. Also, whereas
IMP and ccrA possess a large side-chain residue (W28
and W49, respectively), VIM lacks the aromatic side-
chain and appears one residue shorter than either IMP
or ccrA. Phenylalanine (F70) occupies this position in
NDM-1, which may serve a similar purpose to that of
its analogues in IMP and ccrA. MBL library alignment
t oN D M - 1u s i n gS t r a l S Vi ss h o w ni nF i g u r e3a sa n
abundance plot, and represents the fraction of members
of the MBL library with structural alignment to NDM-1
over all positions. Across all members of the library, the
L3 flap region shows broad disagreement. Graphical
illustration of the structural deviations in this region
relative to the NDM-1 is shown in Figure 2. Other
regions of dissimilarity include the aforementioned lin-
ker region and, interestingly, the L10 loop often asso-
ciated with ligand binding. Most regions otherwise show
strong structural agreement, including areas of short
misalignment between NDM-1 and other MBLs. This
was not surprising, given the conservative fold of MBLs,
and even with short insertions, the overall conformation
of the proteins would not be expected to diverge greatly
[37].
Structure-based clustering
Structure-based clustering of the entire MBL library
showed that MBL folds, including those of the B1
MBLs, group together tightly despite distinct sequence
and structure variability in various regions. On the
whole-chain level within each subclass, structural differ-
ences were generally minimal, and groups of structures
cluster cleanly between B1/2/3 MBLs even for the indi-
vidual B1 types, where ccrA, BcII, VIM, IMP and NDM-
1 form distinct branches (with the exception of NDM-1
structure 3s0z_A, which appears to cluster closer to
VIM; see Additional file 2). This suggests that while
MBLs share a very similar structure, evidenced by the
small distances between types on the tree, there are suf-
ficient and consistent differences at the whole chain
level that distinguish IMP, VIM, ccrA and other B1
MBLs.
Further structural comparisons across the B1/2/3
MBLs focused on areas of known importance, including
the active cavity where zinc ligation occurs. As we were
interested in whether this clustering was also evident
around the conserved binding cavity, spherical protein
substructures with 7.5 Å and centered at the metal ions
were extracted, followed by a second layer of 7.5 Å cen-
tered around the residues found in the initial step; this
two-step approach at spatially defining the active site
provided a substructure centered around the binding
region encompassing both direct and secondary interact-
ing residues.
Examination of the clusters formed by extracting the
active site and its immediate neighborhood paint a
much tighter view of NDM-1, with all instances of the
protein clustering tightly, showing that structural fea-
tures of 3s0z_A outside of the active site are the cause
for division (see Figure 4A). VIM- and ccrA-type pro-
teins cluster closely with NDM-1 at the active site. As
Yong et al. [2] initially proposed that VIM-2 is a close
homolog, the small differences between NDM-1 and
VIM are not surprising. However, we note that ccrA,
despite being a non-transferrable MBL, is strikingly
close in the most critical region to NDM-1, surpassing
IMP in active site similarity; indeed, IMP is quite distant
from the other transferrable MBLs, indicating relatively
strong structural differences between IMP and VIM,
NDM-1. Much of this change can be explained by
IMP’s L10 loop, which is shorter by three residues than
ccrA, VIM or NDM-1, a factor believed to affect inhibi-
tor binding [38].
As mentioned earlier, most discordance between B1
MBLs resided within the linker regions of the proteins.
As was done for the active cavity, structure-based clus-
tering was done for substructures from the correspond-
ing linker regions. These regions were extracted by
using LGA_pdblist to identify N- and C-terminal resi-
dues flanking the linker region that had strong struc-
tural alignment across the MBL library, followed by
structural alignment of only the residues between the
flanking regions; results are shown in Figure 4B. Despite
the structural variability within this long loop region,
most B1 MBLs tended to cluster tightly. However,
NDM-1 clustered quite differently from other B1 MBLs,
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Page 6 of 15indicative of an entirely novel conformation within its
linker region. This deviation, shown in the alignment of
the linker region between NDM-1 and other B1 MBLs
on Figure 5, results in a significant portion of the
NDM-1 linker being exposed. Further manual inspection
of structural alignments of NDM-1 to other proteins in
the same dendrogram branch (CphA, SPM-1) reveal
that the N- and C- terminals align well, but the majority
of NDM-1’s linker region mismatches.
Within VIM-type proteins, structural alignment
reveals that the linker region contains an initial loop
approximately five residues longer than the same region
in IMP. Incorporating ccrA structures into the pairwise
alignment reinforces this five-residue insertion, but also
introduces a second insertion in this linker region, pro-
ducing a loop approximately four residues longer with
respect to VIM-type proteins and two residues longer
than IMP. Among these three types, IMP represented
the structures with both loops short within the linker
region, an interesting observation given IMP’s aforemen-
tioned shorter L10 loop. NDM-1’s linker region is
extended at the N-terminal, a region where it is most
similar to VIM. It then adopts a short helix from posi-
tions 170-174, and continues as a loop.
The structural theme found in B1 MBLs is an
extended loop pattern, whereV I M - t y p es t r u c t u r e sp o s -
sess an initial insertion, followed by a structurally-con-
served region approximately five residues in length
shared by VIM, IMP and ccrA, and ending with an
IMP/ccrA insertion two to four residues in length (see
Figure 1). This is in contrast to earlier sequence-based
alignments, where the initial VIM insert differs in loca-
tion, and the later insert toward the C-terminal end is
entirely absent [2]. The linker region of NDM-1 is a
notable departure from this theme, particularly with the
presence of a helix and loop extension. The comparative
difference of this region across B1 MBL types suggests
the possibility that the linker region is an area of flex-
ibility within MBLs, and that the unusual length and
conformation of NDM-1’s linker region may confer
higher plasticity. Temperature factors of available NDM-
1 crystal structures, while generally higher than other
stable regions of the structure, were not abnormally
high.
Comparison of MBL pockets and binding changes
Estimated calculations of binding site volumes were
higher for the plasmid-borne MBLs versus other MBLs
(see Figure 6). A larger binding pocket for the B1 MBLs
may aid in accommodating a more diverse set of
ligands, and on average IMP-1, VIM-2/4 and NDM-1
have similarly-sized pocket volumes. We also find that
ccrA, which has close structural homology to transmissi-
ble MBLs, has a notably smaller binding pocket site.
For hydrolytic activity, shallower and tighter zinc ions
a r ea s s o c i a t e dw i t hm o r ee f f e c t i v ec a t a l y t i ca c t i v i t y[ 4 0 ] ,
and examination of the distances between the MBL zinc
ions (for di-zinc species) shows that ccrA ion distances
are surprisingly similar to the transferrable MBLs, and
IMP-1 and NDM-1 in particular (see Figure 7). Of the
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Figure 3 Structural abundances of NDM-1 based on MBL structural fragment comparisons. (A) Structural abundance, per residue for
NDM-1. The first major decrease in abundance at approximately residue 68 corresponds to the mobile flap found in B1 MBLs. The region of
structural disagreement starting at about residue 50 and continuing for 30 residues corresponds to the linker region. The last decrease in
abundance, at about residues 210-225 align with a lengthy loop region in other MBLs. The flap, anchored linker region and loop L10 are
demarcated using the ranges specified in Figure 2.
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Figure 4 StralCP dendrograms and clusters for MBL-like proteins. Structure-based similarity dendrograms based on substructures of the (A)
active site, and (B) linker region, constructed using pairwise average-link Euclidean distances. The subtrees are magnified sections of the
dendrograms corresponding to the main branch containing the B1 MBL clusters, as determined via StralCP, where coloring correspond to VIM-
type (red), IMP-type (green), NDM-1 (purple) and ccrA (blue) structures.
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Page 8 of 15plasmid-borne MBLs compared, NDM-1 and IMP
appear to have the tightest zinc arrangement, even with
the inclusion of a > 4 Å outlier (3q6x_A), whose large
inter-zinc distance is likely a result of ampicillin
hydrolysis [23]. NDM-1 accommodates both a relatively
large pocket volume, similar to VIM, with slightly tigh-
ter zinc conformation; these characteristics likely influ-
ence its broad binding and catalytic capabilities.
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Figure 5 Visual alignment of the linker region between NDM-1 and other B1 MBLs. NDM-1 is shown in red, against varying shades of gray
for IMP-1, ccrA, VIM-2 and BlaB. N- and C-terminal regions align well across all B1 MBLs, but for NDM-1 the center of the linker region is distal,
indicated by arrows and labeled by their positioning and residues within NDM-1. The shown structures correspond to 120-166 in ccrA, 98-143 in
IMP-1, 138-200 in VIM-2, 138-200 in BcII and 141-193 in NDM-1; these ranges include N- and C-terminal anchor sequences that flank the linker
region and are generally well conserved. Graphics were generated using PyMol [39].
Figure 6 Estimated pocket volumes of the binding site for ccrA, IMP-1, VIM, NDM-1 and other B1 MBLs. Boxplots show the distribution
of volume for various MBL binding sites; while the plasmid-bourne MBLs (IMP-1, NDM-1, VIM) share similar volume sizes, with fluctuation, ccrA
and other B1 MBLs have a distinctly smaller site. Estimates were calculated using CASTp [23]. Data for generating these plots are from Additional
file 3.
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Page 9 of 15Significant backbone and side-chain changes between
the bound and unbound states of IMP- and VIM-type
proteins, and ccrA and NDM-1 indicated other com-
monalities and differences among the MBLs. Figure 8
shows these changes between bound and unbound crys-
tal structures around the active site. Specifically, binding
across all four MBLs of interest elicits shared, large
structural shifts in the flap region: residues M67, F70 in
N D M - 1( V 2 5 ,W 2 8i nI M P - 1 ;I 2 9 ,W 3 2i nc c r A ;F 4 2 ,
A45 in VIM-2) of the mobile flap are shifted during
binding via a twist of the loop caused by hydrophobic
interactions. Other structural changes are evident in the
L10 active site loop, in particular shifts in K211/K161/
K167 in NDM-1, IMP-1, and ccrA, respectively, a posi-
tion that has been associated with polar ligand binding
activity in B1 MBL members [23,38,41]. In VIM-2, R185
is believed to play a similar role [42], though in strict
residue-residue correspondences from structural align-
ment, Y181 occupies the position of K211 in VIM-2,
and subsequently displays a similar conformational dif-
ference between bound and unbound states (Figure 8).
Comparison of R185 in VIM-2 shows it undergoes less
dramatic a change in conformation, further distinguish-
ing it from the other MBLs (in addition to its relatively
shorter length and residue composition). D212/D168 in
NDM-1/ccrA, undergoes similar changes in conforma-
tion as K211, though the analogous residue in IMP-1,
P162, does not.
Functional and structural residues of interest in B1 MBLs
Structural distinctions between VIM, IMP, ccrA, NDM-
1 and BcII (with residue positioning per PDB structures
2yz3_A, 1dd6_A, 1a8t_A, 3q6x_A and 3fcz_A, for con-
text) are identified for residues within 4 Å of either the
zinc or ligand binding regions, are shown in Table 1,
such as W67 in VIM-2 (2yz3_A numbering; W93 in
NDM-1). This residue was determined to be functionally
important for VIM-2, was shown via mutagenesis to be
integral for stability [28] and is bolded in Table 1 due to
its colocation (within 4 Å) with the ligand, a mercapto-
carboxylate inhibitor [42]. Replacement of this residue
in VIM-2 results in decreased ampicillin resistance.
3q6x_A, bound to hydrolyzed ampicillin, indicates the
nature of the interaction as a hydrophobic, suggesting a
similar antibiotic phenotype [23]. The corresponding
residue in ccrA is an isoleucine, which is the second
most common residue match using StralSV (see Table
1). IMP-1 possesses a relatively uncommon phenylala-
nine, though its effect, if any, on enzymatic function has
not yet been experimentally characterized. Given the
amino acid and similar proximity to an IMP-1 ligand
(also a mercaptocarboxylate inhibitor [38]), an analogous
effect with W93 in NDM-1 is plausible. Structural varia-
bility analysis was also performed using StralSV to iden-
tify additional active site conformations and critical
residues based on rarity in NDM-1, and several residues
w e r en o t e dt ob eu n i q u ei nv a r i o u sp a r t so ft h e
Figure 7 Estimated metal ion distances for ccrA, IMP-1, VIM, NDM-1 and other B1 MBLs. Boxplots show the distribution of inter-zinc
distances; ccrA has the tightest inter-zinc distance, though this does not appear to be statistically significant when compared to the other types
under an adjusted signed rank test. Data for generating these plots are from Additional file 3.
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Page 10 of 15structure (see Additional file 4). Notably, some of these
unique residues appear within the active cavity of
NDM-1, whose structural corollaries in other B1 MBLs
are associated with inhibitor or substrate enzymatic
activity. This includes the uncommon residue at the L3
loop (positions 68-72), phenylalanine (F70).
NDM-1 also shares functional residues with MBLs
outside the IMP, VIM and ccrA types. Earlier directed
evolution studies with BcII indicated several residue
changes implicated with resistance [40]. Notably, the
glycine to serine change at position 262 in BcII maps to
S249 within NDM-1, and S196 in IMP-1 (see Table 1).
In NDM-1, as in BcII, S249/S262 forms a hydrogen
bond with C208 (3.18 Å)/C221 (3.2 Å), directly affecting
the second zinc binding site. This change in BcII is
noted to result in increased cephalexin turnover [40].
The complementary mutation within BcII, N70S, is not
present in NDM-1, though a similar residue, histidine, is
found in IMP-1. Cephalosporin profiles for NDM-1 are
most similar to IMP-1, though turnover is slightly better
for IMP-1 [2,43], and may imply that a mutation of N76
in NDM-1 to H/S76 may result in more efficient cepha-
losporin hydrolysis.
Wholesale comparison of these and other possibly cri-
tical residues were plotted using LGA_pdblist, permit-
ting a view of deviations between functional side chains
of multiple proteins, given a reference. Selection of
atom positions for LGA calculation was done using a
list of functional ends of protein side-chains, as
described in [44]via GDC-sc. Use of NDM-1 as a refer-
ence against representatives of VIM, IMP and ccrA
highlighted areas of inter- and intra-type functional
side-chain difference (Figure 9). Between available
NDM-1 structures, side-chain positioning is generally in
agreement, with the exception of 3s0z_A, which exhibits
notable variation not seen in the other representatives
(we note that 3s0z_A, an unbound structure, is missing
part of the linker region–residues 167-170). Within
NDM-1 structures, we observe consistent differences
between the bound reference (3q6x_A) and the
unbound structures in both R81, the L10 loop and E227
(see annotations on Figure 9). As mentioned in the pre-
vious section, IMP, ccrA and NDM-1 also share a lysine
(K161 in IMP; K211 in NDM-1) at a residue position
associated with mercaptocarboxylate-based inhibition;
this residue was highlighteda su n d e r g o i n gc o n f o r m a -
tional changes between bound and unbound states (Fig-
ure 8). Side-chain comparisons of this residue using
LGA_pdblist show that NDM-1’s K211 adopts a func-
tional side-chain orientation closer to that of IMP-1
than ccrA, despite the larger differences between NDM-
1a n dI M P - 1 ’s overall L10 loop. The presence of these
Figure 8 Structural conformation adjustments within the active sites between bound-unbound structures of NDM-1, IMP-1, VIM-2 and
ccrA. Charts were generated as follows: in each case, a bound reference from one of the four B1 MBL types was selected for examination. The
bound reference was compared to other bound B1 MBL structures using LGA (maximal distance of 4 Å), and similarly to unbound B1 MBL
structures. Residue shifts within a 4 Å distance of either the bound ligand or the dinuclear zincs were drawn on a XY-plot, with the X-axis
referring to differences in the bound target and the unbound templates, and Y-axis the bound target against other bound templates,
alternatively using NDM-1, IMP-1, VIM-2 and ccrA as a bound representative. The horizontal line shows the line of equal change between bound
and unbound comparisons (thus, residues on the top right are residues that deviate in either case). K211/161/167 and R185 (Y181) from NDM-1,
IMP-1, ccrA and VIM-2, a ligand binding-associated residue, are highlighted for comparison in red.
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Page 11 of 15residues at similar locations, and notably in comparable
conformations, for other MBLs within NDM-1 may con-
tribute to its broad binding profile, whose characteristics
are simultaneously close to other B1 MBLs [2].
Close examination of the NDM-1 structures using
side-chain deviations from LGA_pdblist as a guide
reveal possible electrostatic interactions between R81
and W59, and E227 may form a transient salt bridge
with R270. Notably, E227 is located on the turn imme-
diately before the L10 binding loop, and may thus aid
modestly in stabilization. While the same glutamic acid
i sf o u n di nI M P - 1 ,t h e r ea p p e a r sn oR 2 7 0a n a l o g u e .
Comparison of non-covalent interactions between
3q6x_A and NDM-1’s unbound representatives using
VMD [45] further show that additional salt bridges may
form during ligand binding, and that such interactions
are more prevalent in NDM-1 than in IMP-1, VIM-2 or
ccrA.
Emerging research into the mechanisms of MBL pro-
teins indicate that variation in resistance profiles can be
Table 1 StralSV profiles of B1 MBL active site, functional residues For each five B1 MBL proteins, residues within 4 Å
of either the zinc ions or ligand were identified (red denotes metal coordination residues, while bold denotes those in
close proximity to the ligand).
NDM-1 (3q6x_A) IMP-1 (1dd6_A) ccrA (1a8t_A) VIM-2 (2yz3_A) BcII (3fcz_A) NDM-1 StralSV profile Uniqueness, by% shared
L65 E23 A27 Q40 G59 GDLAEVYCNIQRSWTF 15.5
M67 V25 I29 F24 F61 FIDMNHAE 14.1
F70 W28 W32 A45 - WFAGKP 24
V73 V31 V35 Y47 V67 VILYPMDKAGQTRHF 46.4
A74 P32 P36 P48 P68 PTDAVISGQLRWCFYHX 7.9
S75 K33 S37 S49 S69 SGLAYVKDNEIMRTQHFPC 22.9
N76 H34 N38 N50 S70 NSFTYVAHGQELWIXPMDCRK 26.8
W93 F51 I55 W67 W87 WIFSTYKPQAVLDGERM 35.8
A116 S73 F78 A90 A112 VIFLASYNWMGTHCQDX 5.5
H120 H77 H82 H94 H116 HGVPAIYNLTRWDMQEFS 53.4
H122 H79 H84 H96 H118 HGETASNQCKVL 64.4
Q123 S80 G85 D97 A119 ALGSDPNFKTYEQVWHIMR 1.6
D124 D81 D86 D98 D120 DSNTAKVEIFLPCQGH 73.2
K125 S82 C87 R99 R121 HGRCSANTVFKLYDIME 1.3
Q147 E104 D109 R121 E144 EDLQVKGAHNPSRFTXMYI 7.5
M154 K111 L116 N128 Y167 YKLNMPGF 6
H189 H139 H145 H159 H196 HEDKVR 96.9
D202 K152 N158 S172 N215 NRKQADSEHG 5.6
C208 C158 C164 C178 C221 DCSXEKMGR 28
K211 K161 K167 Y181 K224 KFYLVHPGR 68.6
D212 P162 D168 E182 S225 SDTEIVA 24.8
A215 - T171 R185 A228 ARSTN 78.9
S217 G164 S173 S187 D230 DSEG 38.9
L218 L165 I174 A188 L231 LIA 74.8
G219 G166 G175 G189 G232 GL 99.2
N220 N167 N176 N190 N233 NKYAPR 85.3
E227 E174 T183 A197 N240 ENKTDIALXPSQ 31.6
Y229 W176 W185 W199 W242 WYMVGLARISTHFN 27.7
G237 K184 K193 Q207 S250 KLRQISEGATVYNC 2.9
S249 S196 G205 G219 S262 GSPAYVDE 24.3
H250 H197 H206 H220 H263 HD 99.1
S251 S198 G207 G221 G264 GSDNL 15.6
A252 E199 N208 L222 E265 EODIALPWVNGY 6.9
These structures were selected because unlike the references structures used to build the MBL library they are ligand bound, with the exception of BcII (3fcz_A).
Structural alignments were then used to identify residue-residue correspondences for five B1 MBL proteins for those given residues. For NDM-1, the
corresponding StralSV profile is provided, showing several positions in NDM-1, that are either around the binding pocket or are associated with resistance, are
rare or uncommon for their corresponding locations in other MBLs, such as 125 K, 123Q, 237 G, 252A, 154 M (full StralSV output is provided in Additional file 4).
Note that the residue numbering is according to the PDB structure provided in parentheses: 3q6x_A, 1dd6_A, 1a8t_A, 2yz3_A and 3fcz_A for NDM-1, IMP-1, ccrA,
VIM-2 and BcII, respectively. The residue numbering for VIM-2 (2yz3_A) and ccrA (1a8t_A) are different from the residue numbering for the reference VIM-2 and
reference ccrA used throughout the rest of this paper
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Page 12 of 15associated with residue changes distant from the active
site. Studies of VIM variants and residue-specific
changes to members of the IMP type [40,46-48] indicate
that locations distant from the active site may affect
hydrolytic activity. For example, K215 (aligned to a S172
in VIM-2, > 20 Å distant from the active site) in the
recently characterized VIM-19 is associated with
improved carbapenem resistance when R228 is also pre-
sent [48]. The V112A mutation in BcII, similarly distant
from the active site, is associated with increased cepha-
losporin activity, though the association is unclear. As
we noted, mapping of resistance-related BcII regions to
NDM-1 shows it possess two of four associated hydroly-
tically beneficial residues. The presence of multiple, fit-
ness-improving residues within NDM-1 found also in
critical structural and functional regions of a myriad
number of other MBLs suggests incremental and com-
plementary changes in MBL composition, even in
regions distant from ligand binding, can have effects on
resistance that are difficult to predict.
Conclusions
We have sought to characterize structural features of
members of the B1 MBL proteins most closely related
to the recently discovered NDM-1 gene using structural
conservation and comparisons of sequence conservation.
This has included a survey of the structural features of
B1 MBLs from different approaches, including residue
variability at specific substructures, clustering varying
degrees of structural granularity, and examination of the
critical residues of MBLs with an eye toward NDM-1
functionality. While most MBL proteins showed a
tightly conserved overall fold structure, structure-based
sequence variability methods confirmed the strong
structural and sequence conservation at key residues
within the active cavity. From this analysis, we find that
NDM-1 appears to possess several residues found in
variants of IMP, VIM and other MBLs known to confer
resistance-like capabilities.
A striking exception to this is the identification of a
linker region found within MBLs that appears to vary in
structure and length, and is the most divergent and dis-
tinguishing structural feature between the IMP, VIM,
ccrA and NDM-1 proteins. The identification of this
variable linker region within MBLs raised the hypothesis
of a distinctive flexible loop; inspection of VIM-2, ccrA
and IMP-1 revealed no significant changes in the linker
region between apo and holo forms. We identified a
marginal difference between the bound and unbound N-
terminal ends of the NDM-1 loop on the order of ~1.0-
1.5 Å. As the linker region is quite distant from the
active site itself, it is unclear if this is a functional shift
or an artifact of a possibly more flexible region. Addi-
tional study of this region of MBL proteins is necessary
to understand how its conformation may affect MBL
structure or function.
Deeper knowledge of the structure and mechanism
involved in antibiotic resistance in bacteria is highlighted
by the continued emergence of transferrable MBLs such
as NDM-1. This new enzyme is disturbing for both the
speed at which it has spread, its broad capability to bind
many types of b-lactams uncharacteristic of other MBLs
and its colocation with other resistance-granting genes.
Structural alignments of NDM-1 to other B1 MBLs
shows that it simultaneously shares critical resistance-
associated residues with VIM, IMP, ccrA and even BcII,
some of which are distant from the active site. The
notion of a structure displaying motifs from multiple
protein subclasses is not entirely unknown for B1 MBLs;
SPM-1, for example, has structural features found in
both B1 and B2 MBL proteins [49]. As others have pos-
ited, that this may indicate that while the overall MBL
fold structure is critical from a functional standpoint,
there is potential for optimization at the residue and
substructure level via small changes in sequence or con-
formation [50]; in this light, NDM-1’su n i q u e n e s si n
both composition and structure may serve a multitude
of possible function roles, and thus possible targets of
further study.
In the future, we hope to expand our computational
analysis of these important proteins using ligand
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Figure 9 LGA_pdblist functional side-chain differences
between NDM-1 and other B1 MBLs. Using 3q6x_A as a
reference, functional side-chain differences are shown of NDM-1
against IMP-1, VIM-2,4 and ccrA. Measurements are taken only for
instances where the residue-residue correspondence for NDM-1 to
the other MBLs match, and only then for those with functional
sidechains (e.g., alanine, glycine are ignored) [44]. Coloring is from
green (< 2Å) to red (< 8Å), with gray indicating no match. Notable
regions of B1 MBLs are highlighted, and include the zinc binding
region, the L10 ligand-binding loop and the K211 residue noted in
Figure 8. Additional annotations show areas where side-chains
consistently differ from 3q6x_A and either other NDM-1 structures
or other B1 MBLs (e.g., flap region).
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Page 13 of 15screening methods, with the intent to determine resi-
dues or structural features that are broadly critical to
MBL substrate specificity, thus correlating structure
more concretely to phylogenetic profile. The findings
described herein provide promising regions for further
investigation. Furthermore, experimental follow-up
would aid in elucidating the role the linker region may
play in MBLs, including NDM-1, with regard to plasti-
city, function and binding
Additional material
Additional file 1: MBL_library.csv–(Comma-seprated values file)
Enumeration of MBL folds comprising the comparative analysis
library. This file contains a list of all structures included in the described
MBL library (see 2.1), as well as their type classification.
Additional file 2: Whole_chain_clustering–(Portable document
format file) Whole-chain clustering of B1 MBL library using StralCP.
This supplemental figure is the whole chain dendrogram for the B1
library, and is depicted in similar form and labeling as Figure 4.
Additional file 3: B1_MBL_active_site_measurements.csv–(Comma-
separated values file) Measurements for active sites of selected
MBLs. Each row-wise record of this file contains information regarding
the active site of the PDB entry noted in the first column. This data
includes: the B1 type, the area and volume of the active site (as
estimated by CASTp), an indicator variable associated with the presence
of a bound ligand in the active site (1 for a present ligand, 0 otherwise),
and the measured metal ion distances for di-zinc MBLs (cases where one
or less metal ions are present is designated by a dash).
Additional file 4: 3q6x_A_StralSV_w90_5.txt–(Text file) StralSV
output for NDM-1 structure 3q6x_A. This file contains the raw output
of the StralSV algorithm run on 3q6x_A using the entire PDB (release
2011/08/02). The header of the file contains structural matches (by
region) of various PDB templates to NDM-1, followed by the annotations
of the templates. The main body of the file consists of the StralSV output
profile, where the first data column is the amino acid; the second
column is the position of that amino acid in the profile (starting at 1);
the third column is the position of the amino acid in the sequence itself;
the fourth column denotes the rank of the amino acid present relative to
the structural match profile; the fifth column indicates the percentage of
matched structures which have an exact residue-residue correspondence
to present amino acid; columns six, seven and eight are the percentages
of matched structures which contain the most prevalent, second-most
prevalent and third-most prevalent residues, respectively; columns nine
and ten are the fraction and number of structural hits; the eleventh
column is the StralSV profile itself, sorted by the frequency of the amino
acid occupying the position to which the present amino acid aligns; the
following columns are indicators for various amino acid categories (see
header) and unused measures of conservation.
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